(Q35753968)

English

Use of fluorescence in situ hybridization to predict response to bacillus Calmette-Guérin therapy for bladder cancer: results of a prospective trial

scientific article published on 15 January 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Use of fluorescence in situ hybridization to predict response to bacillus Calmette-Guérin therapy for bladder cancer: results of a prospective trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

1 reference

based on heuristic

inferred from title

1

object named as

Ashish M Kamat

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

author name string

Rian J Dickstein

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Fabrizio Messetti

3

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Roosevelt Anderson

4

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Shanna M Pretzsch

5

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Graciela Noguera Gonzalez

6

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Ruth L Katz

7

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Abha Khanna

8

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Tanweer Zaidi

9

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Xifeng Wu

10

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

H Barton Grossman

11

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Colin P Dinney

12

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

language of work or name

0 references

publication date

15 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Journal of Urology

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

187

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

862-867

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Fluorescence in situ hybridization for detecting urothelial carcinoma: a clinicopathologic study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278506

2 October 2017

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278506

2 October 2017

Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278506

2 October 2017

A multicolour fluorescence in situ hybridization test predicts recurrence in patients with high-risk superficial bladder tumours undergoing intravesical therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278506

25 September 2018

Clinical utility of fluorescent in situ hybridization for the surveillance of bladder cancer patients treated with bacillus Calmette-Guérin therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278506

25 September 2018

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278506

25 September 2018

Monitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278506

25 September 2018

Is bladder biopsy necessary at three or six months post BCG therapy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278506

25 September 2018

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278506

25 September 2018

Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278506

25 September 2018

Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22245325

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22245325

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings

1 reference

https://pubmed.ncbi.nlm.nih.gov/22245325

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22245325

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy for bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22245325

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

UroVysion multiprobe FISH in urinary cytology

1 reference

https://pubmed.ncbi.nlm.nih.gov/22245325

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interim results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alfa-2b for superficial bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22245325

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Superficial bladder cancer: progression and recurrence

1 reference

https://pubmed.ncbi.nlm.nih.gov/22245325

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is transurethral biopsy of the bladder necessary after 3 months to evaluate response to bacillus Calmette-Guerin therapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22245325

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22245325

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.JURO.2011.10.144

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35753968&oldid=2223687530"